Complement Inhibitor Eculizumab in Clinical Islet Transplantation (ICC)

Clinical Trial ID NCT02727608

Rank	Title	Journal	Year	PubWeight™‹?›
1	Five-year follow-up after clinical islet transplantation.	Diabetes	2005	7.86
2	Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation.	Lancet	2002	2.76
3	Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?	Diabetes	1999	1.65
4	Positron emission tomography in clinical islet transplantation.	Am J Transplant	2009	1.37
5	Visualization of early engraftment in clinical islet transplantation by positron-emission tomography.	N Engl J Med	2007	1.29
6	Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success.	Transplantation	2010	1.10
7	Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model.	Transplantation	2007	1.05
8	Quantification of the islet product: presentation of a standardized current good manufacturing practices compliant system with minimal variability.	Transplantation	2011	0.88